About Kreatech
Kreatech is a company based in Amsterdam (Netherlands) founded in 1996 was acquired by Leica Biosystems in July 2013. Kreatech has raised $3.02 million across 1 funding round from investors including Life Sciences Partners, Alafi Capital and Leica Biosystems. Kreatech operates in a competitive market with competitors including Parse Biosciences, Biofidelity, RareCyte, Qiagen and RainDance, among others.
- Headquarter Amsterdam, Netherlands
- SectorsHealthcare
- Website kreatech.com
- Social LinkedIn
- Acquired by Leica Biosystems (Jul 2013)
- Total Equity Funding$3.02M (USD)
in 1 rounds
- Latest Funding Round$3.02M (USD), Series A
Nov 2009
- InvestorsLife Sciences Partners
& 2 more
- Acquired byLeica Biosystems
(Jul 2013)
Funding Insights of Kreatech
Kreatech has successfully raised a total of $3.02M through 1 strategic funding round. The most recent funding activity was a Series A round of $3.02 million completed in November 2009. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $3.02M
- Total Rounds 1
- Last Round Series A — $3.02M
- First Round $3.02M
(Nov 2009)
- Investors Count 2
All 1 funding rounds of Kreatech with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2009 | $3.02M | Series A | – | – |
3 investors in total: 3 institutional.
Investors in Kreatech
Kreatech has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Life Sciences Partners, Alafi Capital and Leica Biosystems.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Life-Sciences focused early & growth stage VC firm investing in the US & Europe | – | alafi.com | San Francisco, United States | |
Private equity investments in life sciences businesses are managed. | 1998 | lspvc.com | Amsterdam, Netherlands | |
Provides tools for anatomic pathology, histology, and digital cancer diagnostics worldwide. | 1989 | leicabiosystems.com | Nussloch, Germany |
Investor details for Kreatech
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Kreatech
3 dated milestones of Kreatech across 17 years, from founding to its latest funding, stage changes and deals.
- Founded Kreatech is founded.
- Funding First funding round of $3.0M.
- Exit Acquired by Leica Biosystems.
Competitors of Kreatech
Kreatech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Parse Biosciences, Biofidelity, RareCyte, Qiagen and RainDance, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| parsebiosciences.com | 2018 | Seattle, United States | $100.26M | – | RNA-sequencing transcriptome kits for health data analysis are developed. | |
| biofidelity.com | 2002 | Cambridge, United Kingdom | $59.91M | 28 | Molecular diagnostic assays are developed for target DNA sequence detection. | |
| rarecyte.com | 2009 | Seattle, United States | $114.33M | 54 | Developer of technologies for the analysis of rare and single cells in the blood | |
| qiagen.com | 1984 | Hilden, Germany | – | 104 | Products and reagents for molecular diagnostic assays are supplied. | |
| raindancetech.com | 2004 | Billerica, United States | $111.66M | 105 | Developer of nucleic acid detection and quantification systems | |
| sebia.com | 1967 | Evry Courcouronnes, France | – | – | Electrophoresis-based in vitro diagnostics products are developed and provided. | |
| nuprobe.com | 2016 | George Town, Cayman Islands | $61M | – | Sensitive multiplex platforms for QPCR are developed using toehold probes. | |
| fluentbio.com | 2018 | Watertown, United States | $19M | – | Proprietary reagents for single-cell genetic analysis are developed. | |
| neogen.com | 1982 | Lansing, United States | $700,000 | 2,640 | Manufacturer of products in the areas of veterinary diagnostics, life sciences, DNA testing, and drug testing |
Detailed competitors of Kreatech
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Kreatech
Websites that share an audience with Kreatech (kreatech.com).
Websites whose visitors overlap most with Kreatech. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| ingeny.com | 100% | 680.7K | – | View details | |
omnibiolabs.com | omnibiolabs.com | 100% | – | – | – |
dmbr.ugent.be | dmbr.ugent.be | 100% | – | – | – |
| biomyx.net | 100% | – | – | View details | |
evrogen.com | evrogen.com | 100% | – | #3,545,401 | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 17 similar websites and full traffic analytics for Kreatech
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 17 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Similar companies to Kreatech
10 companies that operate in the same segment as Kreatech (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Kreatech
Kreatech was founded in 1996 and raised its 1st funding round 13 years after it was founded.
Kreatech is headquartered in Amsterdam, Netherlands.
Kreatech is a funded company, having raised a total of $3.02M across 1 funding round to date. The company's 1st funding round was a Series A of $3.02M, raised on Nov 2009.
Kreatech was founded in 1996 in Amsterdam, Netherlands, within the biotechnology sector. FISH probes are developed for detecting and quantifying genetic aberrations linked to cancer and other diseases. A portfolio of REPEAT-FREE DNA-FISH probes is offered, along with microarray labeling solutions based on the proprietary Universal Linkage System technology. Operations focus on enabling diagnostic applications in research and clinical settings.
Kreatech's top competitors include Neogen, Qiagen and Parse Biosciences.
Kreatech has 3 investors. Key investors include Life Sciences Partners, Alafi Capital, and Leica Biosystems.
Yes. Kreatech was acquired by Leica Biosystems in July 2013.